Clinical efficacy of immune checkpoint inhibitors for cancer of unknown primary: a multi-center retrospective study.

BMC Cancer · 2025 · PMC12357449 · PMID 40819041

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In 135 patients, ICIs showed a trend toward improving survival, despite the lack of statistically significant difference in OS and PFS between the two groups.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.